Sarah Dickerson

972 total citations
15 papers, 768 citations indexed

About

Sarah Dickerson is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sarah Dickerson has authored 15 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Sarah Dickerson's work include Viral-associated cancers and disorders (6 papers), CRISPR and Genetic Engineering (4 papers) and Selenium in Biological Systems (3 papers). Sarah Dickerson is often cited by papers focused on Viral-associated cancers and disorders (6 papers), CRISPR and Genetic Engineering (4 papers) and Selenium in Biological Systems (3 papers). Sarah Dickerson collaborates with scholars based in United States, France and Türkiye. Sarah Dickerson's co-authors include Shannon C. Kenney, Wenhai Feng, Prasanna M. Bhende, Xiaoping Sun, M. Joseph Phillips, Thomas G. Chasteen, Kyle A. Wallace, Brian L. Sailer, Enio T. Perez and Lynda S. Wright and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Sarah Dickerson

15 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Dickerson United States 12 416 290 145 119 118 15 768
Zee‐Fen Chang Taiwan 17 553 1.3× 144 0.5× 78 0.5× 130 1.1× 57 0.5× 26 857
Yasunori Fukumoto Japan 19 769 1.8× 223 0.8× 40 0.3× 66 0.6× 28 0.2× 51 1.1k
Hélène Tourrière France 14 1.5k 3.6× 205 0.7× 51 0.4× 51 0.4× 31 0.3× 16 1.6k
Wan Hee Yoon United States 13 420 1.0× 132 0.5× 53 0.4× 130 1.1× 100 0.8× 18 733
Carolyn N. Wrobel United States 7 605 1.5× 214 0.7× 90 0.6× 109 0.9× 57 0.5× 8 837
Carolin Schmidt Germany 12 366 0.9× 91 0.3× 84 0.6× 57 0.5× 53 0.4× 27 593
Lisa Pike United States 11 730 1.8× 68 0.2× 67 0.5× 83 0.7× 82 0.7× 12 1.1k
Nicholas C.K. Valerie United States 10 634 1.5× 314 1.1× 61 0.4× 48 0.4× 56 0.5× 12 858
Bangmin Zhu United States 10 468 1.1× 142 0.5× 38 0.3× 258 2.2× 39 0.3× 15 717
A. Barbara Dirac-Svejstrup United Kingdom 16 1.4k 3.3× 82 0.3× 54 0.4× 63 0.5× 57 0.5× 24 1.7k

Countries citing papers authored by Sarah Dickerson

Since Specialization
Citations

This map shows the geographic impact of Sarah Dickerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Dickerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Dickerson more than expected).

Fields of papers citing papers by Sarah Dickerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Dickerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Dickerson. The network helps show where Sarah Dickerson may publish in the future.

Co-authorship network of co-authors of Sarah Dickerson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Dickerson. A scholar is included among the top collaborators of Sarah Dickerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Dickerson. Sarah Dickerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Brandes, Alissa, A. Koo, Kathryn Michels, et al.. (2024). Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an In Vivo Anti-CD19 CAR T Cell Therapy. Blood. 144(Supplement 1). 2046–2046. 1 indexed citations
2.
Vaidyanathan, Ravi, Sarah Dickerson, Simon Hilcove, et al.. (2024). Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes. Cell stem cell. 31(3). 292–311. 8 indexed citations
3.
Dickerson, Sarah, et al.. (2021). Generation of cryopreserved macrophages from normal and genetically engineered human pluripotent stem cells for disease modelling. PLoS ONE. 16(4). e0250107–e0250107. 5 indexed citations
4.
Phillips, M. Joseph, Enio T. Perez, Jessica Martin, et al.. (2014). Modeling Human Retinal Development with Patient-Specific Induced Pluripotent Stem Cells Reveals Multiple Roles for Visual System Homeobox 2. Stem Cells. 32(6). 1480–1492. 98 indexed citations
5.
Phillips, M. Joseph, Kyle A. Wallace, Sarah Dickerson, et al.. (2012). Blood-Derived Human iPS Cells Generate Optic Vesicle–Like Structures with the Capacity to Form Retinal Laminae and Develop Synapses. Investigative Ophthalmology & Visual Science. 53(4). 2007–2007. 161 indexed citations
6.
Rajesh, Deepika, et al.. (2011). Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells. Blood. 118(7). 1797–1800. 50 indexed citations
7.
Hagemeier, Stacy R., Sarah Dickerson, Meng Qiao, et al.. (2010). Sumoylation of the Epstein-Barr Virus BZLF1 Protein Inhibits Its Transcriptional Activity and Is Regulated by the Virus-Encoded Protein Kinase. Journal of Virology. 84(9). 4383–4394. 50 indexed citations
8.
Dickerson, Sarah, et al.. (2009). Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral Promoters. PLoS Pathogens. 5(3). e1000356–e1000356. 68 indexed citations
9.
Jones, Richard J., William T. Seaman, Elizabeth A. Barlow, et al.. (2007). Roles of lytic viral infection and IL‐6 in early versus late passage lymphoblastoid cell lines and EBV‐associated lymphoproliferative disease. International Journal of Cancer. 121(6). 1274–1281. 50 indexed citations
10.
Jones, Richard J., et al.. (2007). Epstein-Barr Virus Lytic Infection Induces Retinoic Acid-responsive Genes through Induction of a Retinol-metabolizing Enzyme, DHRS9. Journal of Biological Chemistry. 282(11). 8317–8324. 35 indexed citations
11.
Feng, Wenhai, Richard J. Kraus, Sarah Dickerson, et al.. (2007). ZEB1 and c-Jun Levels Contribute to the Establishment of Highly Lytic Epstein-Barr Virus Infection in Gastric AGS Cells. Journal of Virology. 81(18). 10113–10122. 47 indexed citations
12.
Bhende, Prasanna M., Sarah Dickerson, Xiaoping Sun, Wenhai Feng, & Shannon C. Kenney. (2007). X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D. Journal of Virology. 81(14). 7363–7370. 108 indexed citations
13.
Sailer, Brian L., et al.. (2004). Organotellurium compound toxicity in a promyelocytic cell line compared to non-tellurium-containing organic analog. Toxicology in Vitro. 18(4). 475–482. 39 indexed citations
14.
Sailer, Brian L., et al.. (2003). Cytometric determination of novel organotellurium compound toxicity in a promyelocytic (HL-60) cell line. Archives of Toxicology. 77(1). 30–36. 35 indexed citations
15.
Sailer, Brian L., et al.. (1999). Bacterial cytotoxicity and induction of apoptosis in promyelocytic (Line HL-60) cells by novel organotellurium compounds. Environmental Toxicology and Chemistry. 18(12). 2926–2933. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026